Dr. Lisa Kachnic, who chairs Columbia's Department of Radiation Oncology, discusses the major developments in radiation treatment that is creating a more personalized treatment approach for patients.
Researchers at the HICCC and three collaborating institutions have been awarded a $6 million grant from Stand Up To Cancer® for their proposal to address lack of diversity in cancer clinical trials.
March is Multiple Myeloma Awareness month, and in this Q+A, Dr. Rajshekhar Chakraborty takes us through where we are today in multiple myeloma research and treatment.
A paper by HICCC members Drs. Andrea Califano and Barry Honig demonstrates OncoSig, an integrative machine learning framework for systematic protein-centric reconstruction of tumor-specific SigMaps.
Lowering levels of a hormone called PTHrP can prevent metastases and improve survival in mice with pancreatic cancer according to a new study, co-led by HICCC Director Anil K. Rustgi, MD.
